FDA Approves Reblozyl, the First and Only Erythroid Maturation Agent, to Treat Anemia in Adults with Lower-Risk Myelodysplastic Syndromes April 7, 2020
GRAIL Announces Validation of Its Multi-Cancer Early Detection Test Published in Annals of Oncology March 31, 2020
Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines March 31, 2020
Bicycle Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates March 10, 2020
